ArticleFrontiers in immunology2025

CRTC1 enhances PD-L1-mediated tumor immunosuppression in non-small cell lung cancer via the Notch1/Akt signaling pathway.

Xujun Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.